Cancer Biomarkers Conference Satellite Symposium

Since the last Cancer Biomarkers Conference, new tests have emerged for predictive biomarkers used to select cancer patients for new molecular-targeted therapies. New immune therapies for their cancer treatment have also emerged. New technologies, such as liquid biopsy, have advanced. Revised guidelines, as well as new guidelines have also been published. Pathologists and oncologists need to know the answers to a host of questions in this rapidly developing field of biomarkers in order to offer the best patient care.